Matches in DBpedia 2014 for { ?s ?p Amonafide (originally AS1413) (INN, trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.It is being developed as an anti-cancer therapy by Antisoma.As of 2008, it is in Phase III clinical trials.e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML).. }
Showing items 1 to 2 of
2
with 100 items per page.
- Amonafide abstract "Amonafide (originally AS1413) (INN, trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.It is being developed as an anti-cancer therapy by Antisoma.As of 2008, it is in Phase III clinical trials.e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML).".
- Amonafide comment "Amonafide (originally AS1413) (INN, trade name Quinamed) is a drug that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and DNA intercalators.It is being developed as an anti-cancer therapy by Antisoma.As of 2008, it is in Phase III clinical trials.e.g. In March 2010 it is Phase III trial against secondary acute myeloid leukaemia (AML).".